1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. DBV Technologies
  6. News
  7. Summary
    DBV   FR0010417345

DBV TECHNOLOGIES

(DBV)
  Report
Real-time Euronext Paris  -  11:35 2022-08-16 am EDT
5.140 EUR   -0.48%
08/12European ADRs Move Slightly Lower in Friday Trading
MT
08/10European ADRs Climb Higher in Wednesday Trading
MT
08/03Kepler Cheuvreux Upgrades DBV Technologies to Buy From Hold
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Move Lower in Thursday Trading

06/09/2022 | 11:03am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
AKARI THERAPEUTICS, PLC -2.67% 1.46 Delayed Quote.-2.67%
AUTOLUS THERAPEUTICS PLC -2.93% 3.65 Delayed Quote.-29.67%
BIONTECH SE -1.30% 160.37 Delayed Quote.-37.79%
CARNIVAL CORPORATION 4.48% 11.19 Delayed Quote.-44.38%
DBV TECHNOLOGIES -0.48% 5.14 Real-time Quote.68.03%
DIAGEO PLC -0.47% 3848 Delayed Quote.-4.66%
FORWARD PHARMA A/S -6.05% 3.73 Delayed Quote.-37.52%
GENFIT -2.31% 4.406 Real-time Quote.2.09%
MEREO BIOPHARMA GROUP PLC -7.69% 1.2 Delayed Quote.-25.00%
NUCANA PLC 1.23% 1.65 Delayed Quote.-30.67%
SPARK NETWORKS SE -2.00% 2.94 Delayed Quote.-6.37%
TRIVAGO N.V. -2.29% 1.71 Delayed Quote.-21.56%
VODAFONE GROUP PLC 1.72% 123.22 Delayed Quote.9.76%
VOXELJET AG 7.02% 6 Delayed Quote.1.69%
WPP PLC 1.04% 833.2 Delayed Quote.-25.57%
ZEALAND PHARMA A/S 13.76% 141.4 Delayed Quote.-14.33%
All news about DBV TECHNOLOGIES
08/12European ADRs Move Slightly Lower in Friday Trading
MT
08/10European ADRs Climb Higher in Wednesday Trading
MT
08/03Kepler Cheuvreux Upgrades DBV Technologies to Buy From Hold
MT
08/02European ADRs Move Lower in Tuesday Trading
MT
08/01DBV TECHNOLOGIES : Reports Second Quarter 2022 Financial Results - Form 8-K
PU
08/01DBV TECHNOLOGIES S.A. Management's Discussion and Analysis of Financial Condition and ..
AQ
08/01DBV Technologies Reports Second Quarter 2022 Financial Results
GL
08/01DBV Technologies Reports Second Quarter 2022 Financial Results
GL
08/01DBV Technologies S.A. Reports Earnings Results for the Second Quarter and Six Months En..
CI
08/01European ADRs Move Higher in Monday Trading
MT
More news
Analyst Recommendations on DBV TECHNOLOGIES
More recommendations
Financials
Sales 2022 7,16 M 7,28 M 7,28 M
Net income 2022 -90,9 M -92,5 M -92,5 M
Net cash 2022 212 M 216 M 216 M
P/E ratio 2022 -6,19x
Yield 2022 -
Capitalization 483 M 491 M 491 M
EV / Sales 2022 37,8x
EV / Sales 2023 31,8x
Nbr of Employees 87
Free-Float 91,6%
Chart DBV TECHNOLOGIES
Duration : Period :
DBV Technologies Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DBV TECHNOLOGIES
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 5,14 €
Average target price 5,75 €
Spread / Average Target 11,9%
EPS Revisions
Managers and Directors
Daniel Tassé Chief Executive Officer & Executive Director
Sébastien Robitaille Chief Financial Officer
Michel de Rosen Non-Executive Chairman
Pharis Mohideen Chief Medical Officer
Pascal Wotling Chief Technical Operations Officer
Sector and Competitors
1st jan.Capi. (M$)
DBV TECHNOLOGIES68.03%494
MERCK KGAA-18.08%82 320
KYOWA KIRIN CO. LTD.2.55%12 985
SK BIOPHARMACEUTICALS CO., LTD.-18.83%4 733
BETTA PHARMACEUTICALS CO., LTD.-37.48%3 138
YUHAN CORPORATION-6.60%3 052